Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Staropoli

Showing results (21-30 of 61) with videos related to

Pageof 7
Sort By:
Pathogens & Immunity|October 11, 2024
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal AntibodiesDelphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
The Journal of Experimental Medicine|September 6, 2024
Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boostingRaphaël Jeger-Madiot, Delphine Planas, Isabelle Staropoli, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Discovery of Bis-Imidazoline Derivatives as New CXCR4 LigandsZhicheng Zhou, Isabelle Staropoli, Anne Brelot, et al.
Frontiers in Immunology|August 10, 2023
Divergent adaptive immune responses define two types of long COVIDJérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, et al.
The Journal of Biological Chemistry|May 24, 2014
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entryJun Jin, Philippe Colin, Isabelle Staropoli, et al.
Heliyon|March 15, 2024
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variantsDelphine Planas, Lin Peng, Lingyi Zheng, et al.
Scientific Reports|November 29, 2025
Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern FranceSimon Galmiche, Laurie Pinaud, Laura Tondeur, et al.
Med (New York, N.Y.)|October 13, 2022
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infectionDelphine Planas, Isabelle Staropoli, Françoise Porot, et al.
Plos One|July 24, 2008
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteinsPatricia Rueda, Karl Balabanian, Bernard Lagane, et al.
Plos Pathogens|December 7, 2018
CCR5 structural plasticity shapes HIV-1 phenotypic propertiesPhilippe Colin, Zhicheng Zhou, Isabelle Staropoli, et al.
Pageof 7

Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Pathogens & Immunity|October 11, 2024
Escape of SARS-CoV-2 Variants KP.1.1, LB.1, and KP3.3 From Approved Monoclonal AntibodiesDelphine Planas, Isabelle Staropoli, Cyril Planchais, et al.
The Journal of Experimental Medicine|September 6, 2024
Modeling memory B cell responses in a lymphoid organ-chip to evaluate mRNA vaccine boostingRaphaël Jeger-Madiot, Delphine Planas, Isabelle Staropoli, et al.
Molecules (Basel, Switzerland)|February 11, 2023
Discovery of Bis-Imidazoline Derivatives as New CXCR4 LigandsZhicheng Zhou, Isabelle Staropoli, Anne Brelot, et al.
Frontiers in Immunology|August 10, 2023
Divergent adaptive immune responses define two types of long COVIDJérôme Kervevan, Isabelle Staropoli, Dorsaf Slama, et al.
The Journal of Biological Chemistry|May 24, 2014
Targeting spare CC chemokine receptor 5 (CCR5) as a principle to inhibit HIV-1 entryJun Jin, Philippe Colin, Isabelle Staropoli, et al.
Heliyon|March 15, 2024
Beta-variant recombinant booster vaccine elicits broad cross-reactive neutralization of SARS-CoV-2 including Omicron variantsDelphine Planas, Lin Peng, Lingyi Zheng, et al.
Scientific Reports|November 29, 2025
Household exposure, demographic and health characteristics associated with SARS-CoV-2 infection in a cohort study in Northern FranceSimon Galmiche, Laurie Pinaud, Laura Tondeur, et al.
Med (New York, N.Y.)|October 13, 2022
Duration of BA.5 neutralization in sera and nasal swabs from SARS-CoV-2 vaccinated individuals, with or without omicron breakthrough infectionDelphine Planas, Isabelle Staropoli, Françoise Porot, et al.
Plos One|July 24, 2008
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteinsPatricia Rueda, Karl Balabanian, Bernard Lagane, et al.
Plos Pathogens|December 7, 2018
CCR5 structural plasticity shapes HIV-1 phenotypic propertiesPhilippe Colin, Zhicheng Zhou, Isabelle Staropoli, et al.
Pageof 7